PhaseBio reports full results of phase 2b trial of bentracimab to reverse ticagrelor’s antiplatelet activity read more 04/04/22
Bausch + Lomb and Clearside Biomedical Announce the U.S. Commercial Launch of XIPERE® (Triamcinolone Acetonide Injectable Suspension) For Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis read more 03/28/22
Silicon Ranch Raises $775 Million in Equity Funding Led by Manulife Investment Management read more 01/06/22
Mindera Health and WellDyne announce a definitive agreement to improve management of moderate-to-severe psoriasis patients read more 01/05/22
Bausch + Lomb and Clearside Biomedical Announce FDA Approval of XIPERE™ (triamcinolone acetonide injectable suspension) for Suprachoroidal Use for the Treatment of Macular Edema Associated with Uveitis read more 10/25/21
MINDERA™ ANNOUNCES PUBLICATION OF AN ECONOMIC EVALUATION OF PRECISION MEDICINE TESTING FOR THE TREATMENT OF PSORIASIS read more 07/19/21
